These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 30571361)
1. Epidemic of Cardiovascular Disease in China: Current Perspective and Prospects for the Future. Shen C; Ge J Circulation; 2018 Jul; 138(4):342-344. PubMed ID: 30571361 [No Abstract] [Full Text] [Related]
2. Prevention of cardiovascular risk factors in women: The lifestyle paradox and stereotypes we need to defeat. Sciomer S; Moscucci F; Maffei S; Gallina S; Mattioli AV Eur J Prev Cardiol; 2019 Apr; 26(6):609-610. PubMed ID: 30373379 [No Abstract] [Full Text] [Related]
3. BENEFIT for all: An ecosystem to facilitate sustained healthy living and reduce the burden of cardiovascular disease. Keesman M; Janssen V; Kemps H; Hollander M; Reimer WSO; Gemert-Pijnen LV; Hoes A; Kraaij W; Chavannes N; Atsma D; Kraaijenhagen R; Evers A; Eur J Prev Cardiol; 2019 Apr; 26(6):606-608. PubMed ID: 30486650 [No Abstract] [Full Text] [Related]
4. 50×50×50: Cardiovascular Health and the Cardiovascular Disease Endgame. Labarthe D; Lloyd-Jones DM Circulation; 2018 Sep; 138(10):968-970. PubMed ID: 29950402 [No Abstract] [Full Text] [Related]
5. Comprehensive risk management for the prevention of cerebro-cardiovascular diseases in Japan. Joint Committee for Comprehensive Risk Management Chart for the Prevention of Cerebro-Cardiovascular Diseases Clin Exp Nephrol; 2017 Oct; 21(5):743-754. PubMed ID: 28975437 [No Abstract] [Full Text] [Related]
12. Highlights of AHA Scientific Sessions 2019: novel approaches in cardiovascular risk reduction. Akoumianakis I Cardiovasc Res; 2020 Jan; 116(1):e16-e18. PubMed ID: 31850503 [No Abstract] [Full Text] [Related]
13. Prevalence of ideal cardiovascular health in a Central European community: results from the Kardiovize Brno 2030 Project. Medina-Inojosa JR; Vinciguerra M; Maugeri A; Kunzova S; Sochor O; Movsisyan N; Geda YE; Stokin GB; Lopez-Jimenez F Eur J Prev Cardiol; 2020 Mar; 27(4):441-443. PubMed ID: 30841746 [No Abstract] [Full Text] [Related]
15. Editorial: Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: An Epidemic that will Boost the Incidence of Cardiovascular Morbidity and Mortality. Athyros VG; Doumas M Curr Vasc Pharmacol; 2018; 16(3):206-208. PubMed ID: 29598814 [No Abstract] [Full Text] [Related]
17. Prevention of Cardiovascular Disease in Women. Saeed A; Kampangkaew J; Nambi V Methodist Debakey Cardiovasc J; 2017; 13(4):185-192. PubMed ID: 29744010 [TBL] [Abstract][Full Text] [Related]
18. Exercise training to reduce cardiovascular risk in patients with metabolic syndrome and type 2 diabetes mellitus: How does it work? Kränkel N; Bahls M; Van Craenenbroeck EM; Adams V; Serratosa L; Solberg EE; Hansen D; Dörr M; Kemps H Eur J Prev Cardiol; 2019 May; 26(7):701-708. PubMed ID: 30317879 [TBL] [Abstract][Full Text] [Related]
19. A modern fairy tale. Ferrari R; Guardigli G; Tavazzi L Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S65-7. PubMed ID: 19675442 [No Abstract] [Full Text] [Related]
20. Management of cardiovascular risk factors in adults with congenital heart disease. Lui GK; Fernandes S; McElhinney DB J Am Heart Assoc; 2014 Oct; 3(6):e001076. PubMed ID: 25359401 [No Abstract] [Full Text] [Related] [Next] [New Search]